Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-12

Clinical Trial Update: Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the safety and efficacy of ziprasidone in pediatric psychotic illnesses, including schizophrenia and affective disorders, with the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Schizophrenia, Affective Disorders | Phase 4 | Status: COMPLETED